Abbvie Inc (NYSE:ABBV) over-valued by 12%
| Website | https://www.abbvie.com/ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2020 |
| Market Cap | $202,390,700,032 |
| Beta | 0.806398 |
| Average Volume | $7,000,978 |
| Last Dividend | 4.96% |
| Price on Feb 19, 2021 | $114.68 |
| Autochartist™ Valuation | $101.42 |
| Conclusion |
12% over-valued |
| Download Report |
